Description
GenX Pharma CJC + GHRP-6 7 mg is an advanced dual-peptide research formulation designed to investigate the complex relationship between Growth Hormone Releasing Hormone (GHRH) and Growth Hormone Secretagogue (GHS) signaling pathways. By combining CJC-1295 and GHRP-6 in a single formulation, this research blend enables scientists to explore how two distinct peptide mechanisms interact to regulate endocrine communication, receptor activation, and growth hormone-related biological processes.
Rather than acting through a single pathway, this carefully balanced formulation allows researchers to evaluate complementary signaling mechanisms that influence hormone regulation, cellular communication, metabolic physiology, and peptide pharmacodynamics. Its dual-action design has made it a valuable addition to laboratories focused on peptide synergy, receptor biology, and advanced endocrine research.
Each pack contains 5 lyophilized vials, with 7 mg of total peptide content per vial, consisting of 2 mg of CJC-1295 and 5 mg of GHRP-6. Manufactured by GenX Pharma under stringent quality standards, every batch is produced for exceptional purity, stability, and consistency, ensuring dependable performance across professional scientific research applications.
Key Features
- Advanced dual-peptide research formulation
- Contains CJC-1295 (2 mg) and GHRP-6 (5 mg) per vial
- Total peptide content: 7 mg per vial
- 5 lyophilized vials per pack
- Designed for studies involving complementary endocrine signaling pathways
- High-purity laboratory-grade formulation
- Widely researched in growth hormone physiology and peptide synergy
- Manufactured under strict quality control standards
- Intended exclusively for laboratory and scientific research applications
How It Works
This dual-peptide formulation combines two research peptides that interact with different biological receptors, allowing investigators to study multiple regulatory pathways simultaneously. CJC-1295 functions as a Growth Hormone Releasing Hormone (GHRH) analogue, interacting with GHRH receptors, while GHRP-6 primarily targets the Growth Hormone Secretagogue Receptor (GHS-R).
Because these peptides utilize separate receptor systems, researchers commonly investigate how their combined activity influences endocrine signaling, peptide receptor cross-talk, intracellular communication, and growth factor regulation. This complementary mechanism makes the formulation particularly valuable for laboratory studies focused on hormone signaling dynamics, peptide pharmacology, and metabolic physiology.
This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.
Contents
Active Ingredients:
- CJC-1295 – 2 mg
- Growth Hormone Releasing Peptide-6 (GHRP-6) – 5 mg
Packaging: 5 Lyophilized Vials
Reviews
There are no reviews yet.